Itau Unibanco Holding S.A. Arcus Biosciences, Inc. Transaction History

Itau Unibanco Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$7.33 - $10.79 $3,401 - $5,006	-464 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$7.29 - $13.38 $2,704 - $4,963	-371 Reduced 44.43%	464 $4,000
Q4 2018 Feb 13, 2019	SELL	$9.74 - $14.5 $1,129 - $1,682	-116 Reduced 12.2%	835 $9,000
Q3 2018 Nov 13, 2018	SELL	$10.88 - $14.95 $369 - $508	-34 Reduced 3.45%	951 $13,000
Q2 2018 Aug 13, 2018	BUY	$12.24 - $17.05 $7,356 - $10,247	601 Added 156.51%	985 $12,000
Q1 2018 May 14, 2018	BUY	$15.44 - $17.71 $5,928 - $6,800	384 New	384 $6,000

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.